Evidence map›Paper›PMID 35035613›Full record

ArticleDisease markers2022

Hypochlorous Acid Can Be the Novel Option for the Meibomian Gland Dysfunction Dry Eye through Ultrasonic Atomization.

Zhiyuan Li, Haiyan Wang, Mo Liang, Zhenghua Li, Yvliang Li, Xiaoping Zhou, Guoping Kuang

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Solving STODS-Surgical Temporary Ocular Discomfort Syndrome.Diagnostics (Basel, Switzerland) · 2023
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zhiyuan LiThe Diagnosis and Treatment Technology Research and Development Centre for Dry Eye and Ocular Surface Disease of Chenzhou, Chenzhou, 423000 Hunan, China.ORCID https://orcid.org/0000-0003-1719-5337
Haiyan WangThe Operation Department of the Affiliated Chenzhou Hospital, Hengyan Medical School, University of South China, Chenzhou, 423000 Hunan, China.
Mo LiangThe Diagnosis and Treatment Technology Research and Development Centre for Dry Eye and Ocular Surface Disease of Chenzhou, Chenzhou, 423000 Hunan, China.
Zhenghua LiThe Diagnosis and Treatment Technology Research and Development Centre for Dry Eye and Ocular Surface Disease of Chenzhou, Chenzhou, 423000 Hunan, China.
Yvliang LiThe Diagnosis and Treatment Technology Research and Development Centre for Dry Eye and Ocular Surface Disease of Chenzhou, Chenzhou, 423000 Hunan, China.
Xiaoping ZhouThe Diagnosis and Treatment Technology Research and Development Centre for Dry Eye and Ocular Surface Disease of Chenzhou, Chenzhou, 423000 Hunan, China.
Guoping KuangThe Diagnosis and Treatment Technology Research and Development Centre for Dry Eye and Ocular Surface Disease of Chenzhou, Chenzhou, 423000 Hunan, China.
Chenzhou First People's Hospital · CNUniversity of South China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDry eye is a multifactor disease which needs comprehensive treatments to keep the homeostasis of ocular surface.

objectiveTo explore the effect of hypochlorous acid on the meibomian gland dysfunction dry eye through ultrasonic atomization.

methodsWe set this study of 0.01% HOCL and 0.1% hyaluronate by ultrasonic atomization. All the data was recorded at the 1

results53 patients have joined this study. There is no statistic difference between them on OSDI (day 15:

conclusions0.01% HOCL improves the

Indexed as

Dry Eye SyndromesAdultAsian PeopleFemaleHumansHypochlorous AcidInflammationMaleMeibomian Gland DysfunctionTearsUltrasonicsHypochlorous Acid

Identifiers

PMID35035613
PMCPMC8754612
OpenAlexW4205100772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.